These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38522059)

  • 21. Topical tacrolimus for allergic eye diseases.
    Erdinest N; Ben-Eli H; Solomon A
    Curr Opin Allergy Clin Immunol; 2019 Oct; 19(5):535-543. PubMed ID: 31169598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vernal Keratoconjunctivitis: A Systematic Review.
    Bruschi G; Ghiglioni DG; Cozzi L; Osnaghi S; Viola F; Marchisio P
    Clin Rev Allergy Immunol; 2023 Aug; 65(2):277-329. PubMed ID: 37658939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-Term Safety and Efficacy of Tacrolimus 0.1% in Severe Pediatric Vernal Keratoconjunctivitis.
    Caputo R; Marziali E; de Libero C; Di Grande L; Danti G; Virgili G; Villani E; Mori F; Bacci GM; Lucenteforte E; Pucci N
    Cornea; 2021 Nov; 40(11):1395-1401. PubMed ID: 34029239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eosinophil cationic protein as a marker for assessing the efficacy of tacrolimus ophthalmic solution in the treatment of atopic keratoconjunctivitis.
    Wakamatsu TH; Tanaka M; Satake Y; Dogru M; Fukagawa K; Igarashi A; Fujishima H
    Mol Vis; 2011 Apr; 17():932-8. PubMed ID: 21541276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New and future treatment approaches for allergic conjunctivitis].
    Kassumeh S; Brunner BS; Priglinger SG; Messmer EM
    Ophthalmologie; 2024 Mar; 121(3):180-186. PubMed ID: 38363381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of Topical Cyclosporine 0.05% the Treatment of Vernal Keratoconjunctivitis.
    Subedi K; Sharma B; Shrestha S
    Nepal J Ophthalmol; 2020 Jan; 12(23):39-47. PubMed ID: 32799238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical calcineurin inhibitors in the treatment of steroid-dependent atopic keratoconjunctivitis.
    Tzu JH; Utine CA; Stern ME; Akpek EK
    Cornea; 2012 Jun; 31(6):649-54. PubMed ID: 22378107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of a Cationic Emulsion of Cyclosporine in Moderate Vernal Keratoconjunctivitis.
    Caputo R; Di Grande L; de Libero C; Marziali E; Mori F; Masini M
    Cornea; 2024 Feb; 43(2):228-232. PubMed ID: 37747690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical cyclosporine in the treatment of allergic conjunctivitis: a meta-analysis.
    Wan KH; Chen LJ; Rong SS; Pang CP; Young AL
    Ophthalmology; 2013 Nov; 120(11):2197-203. PubMed ID: 23743438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic interventions for severe atopic and vernal keratoconjunctivitis in children and young people up to the age of 16 years.
    Kim SE; Nowak V; Quartilho A; Larkin F; Hingorani M; Tuft S; Dahlmann-Noor A
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013298. PubMed ID: 33084033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of topical cyclosporine A 0.05% in vernal keratoconjunctivitis.
    Yücel OE; Ulus ND
    Singapore Med J; 2016 Sep; 57(9):507-10. PubMed ID: 26768065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monotherapy of topical tacrolimus 0.03% in the treatment of vernal keratoconjunctivitis in the pediatric population.
    Samyukta SK; Pawar N; Ravindran M; Allapitchai F; Rengappa R
    J AAPOS; 2019 Feb; 23(1):36.e1-36.e5. PubMed ID: 30664932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical 2% cyclosporine A in preservative-free artificial tears for the treatment of vernal keratoconjunctivitis.
    Kiliç A; Gürler B
    Can J Ophthalmol; 2006 Dec; 41(6):693-8. PubMed ID: 17224949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treating Severe Pediatric Keratoconjunctivitis with Topical Cyclosporine A.
    Biermann J; Bosche F; Eter N; Beisse F
    Klin Monbl Augenheilkd; 2022 Nov; 239(11):1374-1380. PubMed ID: 34731901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double-masked comparison of 0.1% tacrolimus ointment and 2% cyclosporine eye drops in the treatment of vernal keratoconjunctivitis in children.
    Labcharoenwongs P; Jirapongsananuruk O; Visitsunthorn N; Kosrirukvongs P; Saengin P; Vichyanond P
    Asian Pac J Allergy Immunol; 2012 Sep; 30(3):177-84. PubMed ID: 23156846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and Satisfaction of Cyclosporine 0.1% in Patients with Vernal Keratoconjunctivitis.
    Salami E; Righetti G; Cavarzeran F; Leonardi A
    Ocul Immunol Inflamm; 2023 Nov; 31(9):1870-1872. PubMed ID: 35914313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclosporine effects on clinical findings and impression cytology specimens in severe vernal keratoconjunctivitis.
    Avunduk AM; Avunduk MC; Erdöl H; Kapicioglu Z; Akyol N
    Ophthalmologica; 2001; 215(4):290-3. PubMed ID: 11399937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tacrolimus vs. cyclosporine eyedrops in severe cyclosporine-resistant vernal keratoconjunctivitis: A randomized, comparative, double-blind, crossover study.
    Pucci N; Caputo R; di Grande L; de Libero C; Mori F; Barni S; di Simone L; Calvani A; Rusconi F; Novembre E
    Pediatr Allergy Immunol; 2015 May; 26(3):256-261. PubMed ID: 25712437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical ciclosporin in the treatment of vernal keratoconjunctivitis in Rwanda, Central Africa: a prospective, randomised, double-masked, controlled clinical trial.
    De Smedt S; Nkurikiye J; Fonteyne Y; Tuft S; De Bacquer D; Gilbert C; Kestelyn P
    Br J Ophthalmol; 2012 Mar; 96(3):323-8. PubMed ID: 22001151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dermatologic tacrolimus ointment on the eyelids for steroid-refractory vernal keratoconjunctivitis.
    Liu FY; Liu HY; Chu HS; Chen WL; Hu FR; Wang IJ
    Graefes Arch Clin Exp Ophthalmol; 2019 May; 257(5):967-974. PubMed ID: 30852635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.